These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1119326)

  • 1. Effect of long-term increase in the frequence and/or prolongation of dialysis duration on certain clinical manifestations and results of laboratory investigations in patients with chronic renal failure.
    Twardowski Z
    Acta Med Pol; 1975; 16(1):31-44. PubMed ID: 1119326
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of long-term increase in the frequency and/or prolongation of dialysis duration on certain clinical manifestations and results of laboratory investigations in patients with chronic renal failure.
    Twardowski Z
    Hemodial Int; 2004 Jan; 8(1):30-8. PubMed ID: 19379399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of patients dialysed with double Gambro 4 hours, three times per week.
    Mirahmadi KS; Kay JH; Miller JH; Gorman JT; Rosen SM
    Proc Eur Dial Transplant Assoc; 1975; 11():121-6. PubMed ID: 1197244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment with dialysis in chronic kidney failure using the artificial kidney Aue I].
    Lincke HU; Schröcke G
    Z Gesamte Inn Med; 1968 Oct; 23(19):592-5 passim. PubMed ID: 5702922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nerve conduction velocity in chronic kidney failure].
    Reichenmiller HE
    Fortschr Med; 1973 Apr; 91(10):441-6. PubMed ID: 4633663
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis schedule and peripheral neuropathy.
    Cambi V; Svazzi G; Arisi L; Buzio C; Dall'Aglio P; Rossi E; Migone L
    Proc Eur Dial Transplant Assoc; 1973; 10(0):271-81. PubMed ID: 4369915
    [No Abstract]   [Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of long term dialysis therapy on blood prolactin patients with chronic renal failure].
    Pachelski J; Kokot F; Grzeszczak W
    Pol Tyg Lek; 1989 Feb; 44(9):214-6. PubMed ID: 2813182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of ultrafiltration in plate and coil dialysis apparatus].
    Ragni R; Segoloni GP; Giachino G; Alloatti S; Coppo R; Camussi G; Stratta P; Vercellone A
    Minerva Med; 1974 Nov; 65(84):4372-7. PubMed ID: 4437784
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of certain measureable parameters in the evaluation of haemodialysis adequacy.
    Twardowski Z
    Acta Med Pol; 1974; 15(4):245-54. PubMed ID: 4440512
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis].
    Kawamura J; Okabe T; Yamashita A; Sawanishi K; Katõ T
    Hinyokika Kiyo; 1971 Mar; 17(3):157-86. PubMed ID: 5103947
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thoughts on the long-term therapy of patients with chronic kidney disease with the artificial kidney].
    Losse H; Westerboer S
    Hippokrates; 1967 Apr; 38(7):277-81. PubMed ID: 4869399
    [No Abstract]   [Full Text] [Related]  

  • 15. One year follow-up of short dialysis with a membrane highly permeable to middle molecules.
    Man NK; Granger A; Rondon-Nucete M; Zingraff J; Jungers P; Sausse A; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1973; 10(0):236-46. PubMed ID: 4802554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of atrial natriuretic factor on the hematocrit of patients in chronic hemodialysis].
    Burnier M; Porchet M; Waeber B; Wauters JP; Brunner HR
    Schweiz Med Wochenschr; 1987 Dec; 117(49):1953-6. PubMed ID: 2962284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of impotence in male permanent-dialysis patients].
    Loew H; Schulz H; Busch G
    Med Welt; 1975 Sep; 26(37):1651-2. PubMed ID: 809636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limitations of hemodialysis. Expenses for dialysis centralization].
    Blumberg A
    Bull Schweiz Akad Med Wiss; 1970 Jun; 26(1):18-25. PubMed ID: 4992985
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis.
    Macdonald JA; McDonald SP; Hawley CM; Rosman J; Brown F; Wiggins KJ; Bannister K; Johnson DW
    Nephrol Dial Transplant; 2009 Sep; 24(9):2825-31. PubMed ID: 19443649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.